Literature DB >> 21543875

Molecular cloning, overexpression, purification, crystallization and preliminary X-ray diffraction analysis of a purine nucleoside phosphorylase from Bacillus subtilis strain 168.

Nadia Helena Martins1, Andreia Navarro Meza, Camila Ramos Santos, Priscila Oliveira de Giuseppe, Mario Tyago Murakami.   

Abstract

Purine nucleoside phosphorylase (PNP; EC 2.4.2.1) is a key enzyme of the purine-salvage pathway. Its ability to transfer glycosyl residues to acceptor bases is of great biotechnological interest owing to its potential application in the synthesis of nucleoside analogues used in the treatment of antiviral infections and in anticancer chemotherapy. Although hexameric PNPs are prevalent in prokaryotes, some microorganisms, such as Bacillus subtilis, present both hexameric and trimeric PNPs. The hexameric PNP from B. subtilis strain 168, named BsPNP233, was cloned, expressed and crystallized. Crystals belonging to different space groups (P32(1), P2(1)2(1)2(1), P6(3)22 and H32) were grown in distinct conditions with pH values ranging from 4.2 to 10.5. The crystals diffracted to maximum resolutions ranging from 2.65 to 1.70 Å.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543875      PMCID: PMC3087654          DOI: 10.1107/S1744309111010414

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

Review 1.  Enzymes for chemical synthesis.

Authors:  K M Koeller; C H Wong
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Structural analyses reveal two distinct families of nucleoside phosphorylases.

Authors:  Matthew J Pugmire; Steven E Ealick
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

Review 5.  Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.

Authors:  Farhad Ravandi; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2006-12       Impact factor: 6.206

Review 6.  Purine nucleoside phosphorylases: properties, functions, and clinical aspects.

Authors:  A Bzowska; E Kulikowska; D Shugar
Journal:  Pharmacol Ther       Date:  2000-12       Impact factor: 12.310

Review 7.  A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Authors:  Eloan Dos Santos Pinheiro; Octavio Augusto Ceva Antunes; Joseph M D Fortunak
Journal:  Antiviral Res       Date:  2008-06-02       Impact factor: 5.970

8.  Structure of purine nucleoside phosphorylase (DeoD) from Bacillus anthracis.

Authors:  Rosa Grenha; Vladimir M Levdikov; Mark J Fogg; Elena V Blagova; James A Brannigan; Anthony J Wilkinson; Keith S Wilson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-04-09

Review 9.  Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting.

Authors:  Fujun Li; Hans Maag; Tom Alfredson
Journal:  J Pharm Sci       Date:  2008-03       Impact factor: 3.534

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  2 in total

1.  Fifteen novel immunoreactive proteins of Chinese virulent Haemophilus parasuis serotype 5 verified by an immunoproteomic assay.

Authors:  Yanfei Yu; Guangyan Wu; Zhipeng Zhai; Huochun Yao; Chengping Lu; Wei Zhang
Journal:  Folia Microbiol (Praha)       Date:  2014-09-09       Impact factor: 2.099

2.  Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases.

Authors:  Priscila O de Giuseppe; Nadia H Martins; Andreia N Meza; Camila R dos Santos; Humberto D'Muniz Pereira; Mario T Murakami
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.